[ad_1]
Roche continues its efforts to combat the crown and has now partnered with the American company Moderna. The American company recently requested emergency approval for its corona vaccine candidate in the United States and Europe.
Roche, in turn, has launched several corona tests through its Diagnostics division. As part of the collaboration, Roche will use an antibody test in Moderna’s vaccine research trials, Roche announced Wednesday.
When is a revaccination necessary?
The aim of the collaboration is to facilitate the quantitative measurement of antibodies against SARS-CoV-2 and, at the same time, establish a possible correlation between the amount of antibodies and the effect of the vaccine.
Measuring the quantitative level of these antibodies will help Moderna gain insight into the connection between vaccine protection and antibody levels. This could play a role in assessing whether a person needs to be re-vaccinated or in answering other clinically relevant questions. (SDA / koh)
